JBM Healthcare Limited released its monthly return for the period ended 31 July 2026, confirming that both authorised and issued share capital remained unchanged during the month.

• Authorised capital stood at 5.00 billion ordinary shares with a par value of HKD 0.01 each, representing authorised share capital of HKD 50.00 million. No increase or decrease was recorded.

• Issued share capital totalled 822.00 million ordinary shares at month-end, identical to the preceding month. The company held no treasury shares.

• Public float met the Main Board’s 25 % minimum threshold as required under Rule 13.32B, with compliance formally confirmed by the issuer.

• The existing share option scheme showed no outstanding options and no exercises during July. Nevertheless, up to 83.38 million shares could still be issued if options were granted and exercised under the approved scheme (shareholders’ approval obtained on 06 August 2024). No funds were raised from option exercises in the month.

• The company reported no warrants, convertible securities, other equity-linked instruments, or additional share movements for the period.

Overall, JBM Healthcare’s capital structure was static in July 2026, reflecting a stable share base and full adherence to Hong Kong Stock Exchange listing requirements regarding public float.